Pulmonology
A section of Medicina (ISSN 1648-9144).
Section Information
“Pulmonology” is a medical specialty also called “pneumology” or “respiratory medicine” and focuses on the prevention, diagnosis and treatment of diseases involving the respiratory tract.
Being one of five non-communicable disease areas, chronic respiratory disease contributes to the highest mortality and morbidity worldwide and includes diseases such as chronic obstructive Pulmonology disease (COPD), asthma, bronchiectasis, interstitial lung disease and Pulmonology hypertension. Since the lungs are directly exposed to the environment, risk factors for lung disease include smoking, occupational exposure and air pollution, though additional risk factors are emerging in the current era such as aging-related multi-morbidities, emerging nicotine delivery systems (e-cigarettes), climate change and COVID-19.
In recent decades, research has led to groundbreaking findings including better characterization of the developing and adult lung using state-of-the-art methodologies. We have also made progress to better understand pathological disease mechanisms, which has led to the development of numerous clinical trials testing novel pharmacologic agents, but we are far from curing and preventing chronic respiratory disease, especially in an era where aging-related diseases and complications are emerging.
The aim of the section “Pulmonology” of Medicina is to help to propagate state-of-the-art-knowledge and novel findings and observations in the field of acute and chronic respiratory diseases.
Topics of interest include, but are not limited to, the following:
- Basic and clinical research in all respiratory diseases;
- Novel therapies or therapeutic targets;
- Diagnosis and prevention of respiratory diseases;
- Respiratory disease and beyond—associated comorbidities and inter-organ crosstalk.
Keywords
- Acute and chronic airway diseases
- Lung fibrosis
- Lung cancer and infection
- Pulmonology embolism
- Pulmonology hypertension
- Prevention
- Pathophysiology and pathobiology
- Development
- Aging
- Prevention
- Environmental diseases
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Thoracic Surgery and Lung Cancer Treatment (Deadline: 15 May 2026)
- Bronchiectasis (Deadline: 20 May 2026)
- Advances in Imaging and Diagnostics in Lung Disease: A Multimodal Approach (Deadline: 31 May 2026)
- Pulmonary Fibrosis: Current Understanding and Future Directions (Deadline: 28 June 2026)
- Advances in Interstitial Lung Diseases: From Diagnosis to Treatment (Deadline: 20 July 2026)
- New Trends in Chronic Obstructive Pulmonary Disease (COPD) (Deadline: 31 July 2026)
- Diagnosis and Treatment of Obstructive Sleep Apnea (Deadline: 10 August 2026)
- Pulmonary Sarcoidosis: Diagnosis and Treatment (Deadline: 20 September 2026)
- Obstructive Sleep Apnea: New Insights and Future Directions (Deadline: 30 September 2026)
- Advancements in Lung Cancer Diagnosis and Treatment (Deadline: 30 September 2026)
- Asthma Exacerbations and Respiratory Management (Deadline: 20 October 2026)
- Chronic Respiratory Diseases: Updates on Pathophysiology, Symptoms, Diagnosis and Treatment: 2nd Edition (Deadline: 30 October 2026)
- Lung Injury and Acute Respiratory Distress Syndrome: New Insights into Mechanisms and Emerging Therapies (Deadline: 31 October 2026)
- Clinical and Translational Approaches to Understanding Aging in Lung Disease (Deadline: 31 October 2026)
- Advances in Rare Diseases Affecting the Respiratory System (Deadline: 20 November 2026)
